Wu, Man http://orcid.org/0009-0005-5638-0131
Hau, Pok Man
Li, Linxian
Tsang, Chi Man http://orcid.org/0000-0001-6817-4590
Yang, Yike http://orcid.org/0000-0001-8256-6865
Taghbalout, Aziz
Chung, Grace Tin-Yun
Hui, Shin Yee http://orcid.org/0009-0003-2934-9820
Tang, Wing Chung
Jillette, Nathaniel
Zhu, Jacqueline Jufen http://orcid.org/0000-0001-6416-4563
Lee, Horace Hok Yeung
Kong, Ee Ling
Chan, Melissa Sue Ann
Chan, Jason Ying Kuen http://orcid.org/0000-0002-9480-4637
Ma, Brigette Buig Yue http://orcid.org/0000-0003-4802-1102
Chen, Mei-Ru
Lee, Charles http://orcid.org/0000-0001-7317-6662
To, Ka Fai http://orcid.org/0000-0003-4919-3707
Cheng, Albert Wu http://orcid.org/0000-0003-2653-5743
Lo, Kwok-Wai http://orcid.org/0000-0002-3488-6124
Article History
Received: 7 June 2023
Accepted: 17 April 2024
First Online: 3 May 2024
Competing interests
: K.W.L., A.W.C., P.M.H. and M.W. have filed a patent application “Activation of lytic genes in cancer cells” (WO 2021/173977A9; PCT/US2021/019880); K.W.L., M.W., P.M.H. and C.M.T. have filed a US provisional patent application, “Synthetic mRNAs for treatment of EBV-associated diseases” (no. 63/462,197). K.W.L., C.M.T. and M.W. are cofounders of ACE NanoMed Ltd. K.W.L. received research funding from Viracta Therapeutics and ScinnoHub Pharmaceutical Co., Ltd. B.Y.Y.M. is a consultant for Viracta Therapeutics, Alentis and Y-biologics, serves on the advisory boards of MSD, BMS, Novartis and Taiho; and has received research funding from Boerhinger Ingelheim and Merck Serono. All other authors declare no competing interests. J.Y.K.C. is cofounder of Agilis Robotics and has received research funding from MSD.